Shares of Evoke plc (LON:EVOK - Get Free Report) traded down 18.7% during trading on Wednesday . The stock traded as low as GBX 56 ($0.72) and last traded at GBX 58.05 ($0.75). 55,595,465 shares traded hands during trading, an increase of 1,853% from the average session volume of 2,847,325 shares. The stock had previously closed at GBX 71.40 ($0.92).
Analyst Upgrades and Downgrades
A number of brokerages recently weighed in on EVOK. Berenberg Bank dropped their price target on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a "buy" rating on the stock in a research note on Wednesday, December 4th. Jefferies Financial Group reaffirmed a "buy" rating and set a GBX 140 ($1.81) price target on shares of Evoke in a research note on Monday, December 16th.
View Our Latest Research Report on Evoke
Evoke Stock Performance
The stock has a market cap of £224.78 million, a price-to-earnings ratio of -1.26 and a beta of 0.84. The firm's 50-day simple moving average is GBX 68.88 and its two-hundred day simple moving average is GBX 63.49.
Evoke (LON:EVOK - Get Free Report) last issued its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. Equities research analysts expect that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insider Activity at Evoke
In other Evoke news, insider Andrea Gisle Joosen purchased 14,572 shares of the business's stock in a transaction on Tuesday, January 28th. The stock was acquired at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,189.04). 27.00% of the stock is owned by insiders.
Evoke Company Profile
(
Get Free Report)
Read More
Before you consider Evoke, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.
While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.